BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sultan KS, Berkowitz JC, Khan S. Combination therapy for inflammatory bowel disease. World J Gastrointest Pharmacol Ther 2017; 8(2): 103-113 [PMID: 28533919 DOI: 10.4292/wjgpt.v8.i2.103]
URL: https://www.wjgnet.com/2308-3840/full/v8/i2/103.htm
Number Citing Articles
1
Ian Edwin Cock. Is the pharmaceutical industry’s preoccupation with the monotherapy drug model stifling the development of effective new drug therapies?Inflammopharmacology 2018; 26(3): 861 doi: 10.1007/s10787-018-0488-7
2
Laura M. Jacobsen, Brittney N. Newby, Daniel J. Perry, Amanda L. Posgai, Michael J. Haller, Todd M. Brusko. Immune Mechanisms and Pathways Targeted in Type 1 DiabetesCurrent Diabetes Reports 2018; 18(10) doi: 10.1007/s11892-018-1066-5
3
Fernando Magro, Gonçalo Cordeiro, Andreia Martins Dias, Maria Manuela Estevinho. Inflammatory Bowel Disease – Non-biological treatmentPharmacological Research 2020; 160: 105075 doi: 10.1016/j.phrs.2020.105075
4
Sheng Zhang Lim, Eng Wee Chua. Revisiting the Role of Thiopurines in Inflammatory Bowel Disease Through Pharmacogenomics and Use of Novel Methods for Therapeutic Drug MonitoringFrontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.01107
5
Marisa Iborra, Julia Herreras, Marta Maia Boscá-Watts, Xavier Cortés, Galo Trejo, Elena Cerrillo, David Hervás, Miguel Mínguez, Belén Beltrán, Pilar Nos. Withdrawal of Azathioprine in Inflammatory Bowel Disease Patients Who Sustain Remission: New Risk Factors for RelapseDigestive Diseases and Sciences 2019; 64(6): 1612 doi: 10.1007/s10620-018-5429-1
6
Waseem Ahmed, Jonathan Galati, Anand Kumar, Paul J. Christos, Randy Longman, Dana J. Lukin, Ellen Scherl, Robert Battat. Dual Biologic or Small Molecule Therapy for Treatment of Inflammatory Bowel Disease: A Systematic Review and Meta-analysisClinical Gastroenterology and Hepatology 2021;  doi: 10.1016/j.cgh.2021.03.034
7
Aliakbar Yousefi‐Ahmadipour, Amir Rashidian, Mohammad Reza Mirzaei, Alireza Farsinejad, Fatemeh PourMohammadi‐Nejad, Mahmoud Ghazi‐Khansari, Jafar Ai, Sadegh Shirian, Amir Allahverdi, Jamileh Saremi, Somayeh Ebrahimi‐Barough. Combination therapy of mesenchymal stromal cells and sulfasalazine attenuates trinitrobenzene sulfonic acid induced colitis in the rat: The S1P pathwayJournal of Cellular Physiology 2019; 234(7): 11078 doi: 10.1002/jcp.27944
8
Taku Kobayashi, Eri Udagawa, Akihito Uda, Toshifumi Hibi, Tadakazu Hisamatsu. Impact of immunomodulator use on treatment persistence in patients with ulcerative colitis: A claims database analysisJournal of Gastroenterology and Hepatology 2020; 35(2): 225 doi: 10.1111/jgh.14825
9
Shinsuke Kumei, Toshihiro Sakurai, Suketo So, Soichi Itaba, Hirotada Akiho, Shigeo Nakamura, Hyonji Kim, Masahiro Yamasaki, Noritaka Takatsu, Ryuichiro Maekawa, Ryosuke Sakemi, Tatsuyuki Watanabe, Michihiko Shibata, Keiichiro Kume, Ichiro Yoshikawa, Yasuhiro Takaki, Masaru Harada. Impact of the Concomitant Use of Immunomodulator and a Lower Week 8 Partial Mayo Score on the Persistence of Adalimumab in Refractory Ulcerative ColitisInternal Medicine 2021; 60(24): 3849 doi: 10.2169/internalmedicine.7279-21
10
Milan Buc. Current and prospective biologics and small molecules in the treatment of inflammatory bowel diseasesVnitřní lékařství 2018; 64(3): 280 doi: 10.36290/vnl.2018.039
11
Seong Ji Choi, Min Sun Kim, Eun Sun Kim, Juneyoung Lee, Jae Min Lee, Hyuk Soon Choi, Bora Keum, Yoon Tae Jeen, Hong Sik Lee, Hoon Jai Chun, Chang Duck Kim. Higher risk of tuberculosis in combination therapy for inflammatory bowel diseaseMedicine 2020; 99(44): e22897 doi: 10.1097/MD.0000000000022897
12
Mahnur Haider, Bret Lashner. Dual Targeted Therapy for the Management of Inflammatory Bowel DiseaseJournal of Clinical Gastroenterology 2021; 55(8): 661 doi: 10.1097/MCG.0000000000001583
13
Kristina Lampič, Jurij Trontelj, Helena Prosen, David Drobne, Alenka Šmid, Tomaž Vovk. Determination of 6-thioguanine and 6-methylmercaptopurine in dried blood spots using liquid chromatography-tandem mass spectrometry: Method development, validation and clinical applicationClinica Chimica Acta 2019; 499: 24 doi: 10.1016/j.cca.2019.08.024
14
Shikha Nayar, Judy H. Cho. From single-target to cellular niche targeting in Crohn's disease: intercepting bad communicationseBioMedicine 2021; 74: 103690 doi: 10.1016/j.ebiom.2021.103690
15
Abhinav Vasudevan, Ajay Raghunath, Shane Anthony, Cian Scanlon, Miles P. Sparrow, Peter R. Gibson, Daniel R. van Langenberg. Higher Mucosal Healing with Tumor Necrosis Factor Inhibitors in Combination with Thiopurines Compared to Methotrexate in Crohn’s DiseaseDigestive Diseases and Sciences 2019; 64(6): 1622 doi: 10.1007/s10620-018-5422-8
16
Keith Sultan, Noah Becher. Inflammatory Bowel DiseaseClinical Gastroenterology 2021; : 61 doi: 10.1007/978-3-030-81780-0_3